Evidence map›Paper›PMID 40251201›Full record

ArticleScientific reports2025

Impact of enzymatic isolation on the propagation efficiency of patient-derived colorectal cancer organoids.

Gizem Calibasi-Kocal, Tolga Sever, Aras Emre Canda, Leman Evren Kadioglu, Halil Ates, Yasemin Basbinar, Ender Ellidokuz

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gizem Calibasi-KocalDepartment of Translational Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Türkiye. gizem.calibasi@deu.edu.tr.
Tolga SeverDepartment of Oncology, Institute of Health Sciences, Dokuz Eylul University, Izmir, Turkey.
Aras Emre CandaPrivate Clinic for Colorectal Cancer Surgery and Peritoneal Carcinomatosis, Izmir, Turkey.
Leman Evren KadiogluDepartment of Pathology, Acibadem Izmir Kent Hospital, Izmir, Turkey.
Halil AtesInstitute of Oncology, Dokuz Eylul University, Izmir, Turkey.
Yasemin BasbinarDepartment of Translational Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Türkiye.
Ender EllidokuzDepartment of Internal Diseases, Gastroenterology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer organoids are three-dimensional in vitro models that closely replicate the genetic, phenotypic, and heterogeneity characteristics of original tumors, making them valuable tools in cancer research. However, the lack of standardized protocols limits their broader application. This study evaluates the role of enzymatic isolation in generating patient-derived organoids (PDOs) from colorectal cancer tissues by comparing four enzymatic methods: TrypLE, Trypsin-EDTA (T/E), Collagenase, and Hyaluronidase. Colorectal cancer tissues were processed using these enzymes, and cell viability, dissociation efficiency, and isolation quality were assessed via Trypan Blue exclusion assay and 7-AAD staining with flow cytometry. Cancer stem cells marked by LGR5 and CD133 were quantified via flow cytometry, while organoid generation and growth were monitored over 11 days using confocal microscopy. TrypLE and T/E demonstrated superior preservation of cell viability but limited dissociation efficiency, yielding lower cell count per milligram of tissue. In contrast, Collagenase and Hyaluronidase demonstrated superior tissue dissociation, yielding higher total cell counts and the highest proportions of LGR5

Indexed as

Colorectal NeoplasmsOrganoidsCell SeparationCell SurvivalCollagenasesHumansHyaluronoglucosaminidaseNeoplastic Stem CellsTrypsinCollagenasesHyaluronoglucosaminidaseTrypsinColorectal cancerEnzymatic cell isolationOrganoid culture

Identifiers

PMID40251201
PMCPMC12008271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.